Featured awards of Marc Cox
This Featured Award page displays a list that summarizes all grant awards received by an investigator and processed by R&I.
IDENTIFICATION, CHARACTERIZATION. AND TARGETING OF NOVEL FACTORS AND PATHWAYS DRIVING PROSTATE CANCER PROGRESSION
Start Date: 3-14-2024
End Date: 11-30-2024
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
IDENTIFICATION, CHARACTERIZATION. AND TARGETING OF NOVEL FACTORS AND PATHWAYS DRIVING PROSTATE CANCER PROGRESSION
Start Date: 1-4-2024
End Date: 1-3-2025
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
IDENTIFICATION AND CHARACTERIZATION OF NOVEL FACTORS AND PATHWAYS DRIVING
Start Date: 3-1-2023
End Date: 10-31-2023
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
IDENTIFICATION AND CHARACTERIZATION OF NOVEL FACTORS AND PATHWAYS DRIVING PROSTATE CANCER PROGRESSION
Start Date: 3-3-2022
End Date: 11-3-2022
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
UTEP/UTMDACC PARTNERSHIP FOR HISPANIC CANCER DISPARITIES RESEARCH
Start Date: 8-31-2021
End Date: 8-30-2026
Sponsor: CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS
FUNCTIONAL CHARACTERIZATION OF FKBP PROTEINS AS THERAPEUTIC TARGETS FOR THE TREATMENT OF CANCER AND VIRAL INFECTION
Start Date: 4-1-2021
End Date: 11-30-2021
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
ASSESSING DRUG COMBINATIONS FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 3-1-2021
End Date: 2-28-2022
Sponsor: NIH - NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES THROUGH TEXAS SOUTHERN UNIVERSITY
THERAPEUTIC TARGETING OF ANDROGEN RECEPTOR-ASSOCIATED COCHAPERONES FOR THE TREATMENT OF BREAST AND PROSTATE CANCER
Start Date: 4-1-2020
End Date: 12-31-2020
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
BORDER BIOMEDICAL RESEARCH CENTER
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES
PHASE II OF BUILDING SCHOLARS - TRAINING CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PHASE II OF BUILDING SCHOLARS - ADMINISTRATIVE CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PHASE II OF BUILDING SCHOLARS - INSTITUTIONAL DEVELOPMENT CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PHASE II OF BUILDING SCHOLARS - RESEARCH ENRICHMENT CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PROOF-OF-CONCEPT STUDY OF SURFACE-DIRECTED AR INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 4-1-2019
End Date: 3-31-2020
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
IDENTIFICATION OF A LEAD GMC1 FAMILY COMPOUND FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 11-15-2018
End Date: 11-14-2019
Sponsor: MAIA BIOTECHNOLOGY
IDENTIFICATION OF A LEAD MJC13 FAMILY COMPOUND FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 1-1-2019
End Date: 12-31-2019
Sponsor: MAIA BIOTECHNOLOGY
R13: SOCIETY FOR BASIC UROLOGIC RESEARCH ANNUAL MEETING: PRECISION MEDICINE IN UROLOGY: MOLECULAR MECHANISMS, DIAGNOSTICS AND THERAPEUTIC TARGETS
Start Date: 10-29-2018
End Date: 10-28-2019
Sponsor: NIH - NATIONAL CANCER INSTITUTE
A NOVEL APPROACH TO TREATING CASTRATION RESISTANT PROSTATE CANCER
Start Date: 6-1-2018
End Date: 1-31-2019
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
DIRECT TARGETING OF THE FKBP52 COCHAPERONE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
Start Date: 7-1-2017
End Date: 6-30-2020
Sponsor: CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAM
IDENTIFICATION, CHARACTERIZATION. AND TARGETING OF NOVEL FACTORS AND PATHWAYS DRIVING PROSTATE CANCER PROGRESSION
Start Date: 3-14-2024
End Date: 11-30-2024
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
IDENTIFICATION, CHARACTERIZATION. AND TARGETING OF NOVEL FACTORS AND PATHWAYS DRIVING PROSTATE CANCER PROGRESSION
Start Date: 1-4-2024
End Date: 1-3-2025
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
IDENTIFICATION AND CHARACTERIZATION OF NOVEL FACTORS AND PATHWAYS DRIVING
Start Date: 3-1-2023
End Date: 10-31-2023
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
IDENTIFICATION AND CHARACTERIZATION OF NOVEL FACTORS AND PATHWAYS DRIVING PROSTATE CANCER PROGRESSION
Start Date: 3-3-2022
End Date: 11-3-2022
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
UTEP/UTMDACC PARTNERSHIP FOR HISPANIC CANCER DISPARITIES RESEARCH
Start Date: 8-31-2021
End Date: 8-30-2026
Sponsor: CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS
FUNCTIONAL CHARACTERIZATION OF FKBP PROTEINS AS THERAPEUTIC TARGETS FOR THE TREATMENT OF CANCER AND VIRAL INFECTION
Start Date: 4-1-2021
End Date: 11-30-2021
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
ASSESSING DRUG COMBINATIONS FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 3-1-2021
End Date: 2-28-2022
Sponsor: NIH - NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES THROUGH TEXAS SOUTHERN UNIVERSITY
THERAPEUTIC TARGETING OF ANDROGEN RECEPTOR-ASSOCIATED COCHAPERONES FOR THE TREATMENT OF BREAST AND PROSTATE CANCER
Start Date: 4-1-2020
End Date: 12-31-2020
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
BORDER BIOMEDICAL RESEARCH CENTER
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES
PHASE II OF BUILDING SCHOLARS - TRAINING CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PHASE II OF BUILDING SCHOLARS - ADMINISTRATIVE CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PHASE II OF BUILDING SCHOLARS - INSTITUTIONAL DEVELOPMENT CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PHASE II OF BUILDING SCHOLARS - RESEARCH ENRICHMENT CORE
Start Date: 7-1-2019
End Date: 6-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PROOF-OF-CONCEPT STUDY OF SURFACE-DIRECTED AR INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 4-1-2019
End Date: 3-31-2020
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
IDENTIFICATION OF A LEAD GMC1 FAMILY COMPOUND FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 11-15-2018
End Date: 11-14-2019
Sponsor: MAIA BIOTECHNOLOGY
IDENTIFICATION OF A LEAD MJC13 FAMILY COMPOUND FOR THE TREATMENT OF PROSTATE CANCER
Start Date: 1-1-2019
End Date: 12-31-2019
Sponsor: MAIA BIOTECHNOLOGY
R13: SOCIETY FOR BASIC UROLOGIC RESEARCH ANNUAL MEETING: PRECISION MEDICINE IN UROLOGY: MOLECULAR MECHANISMS, DIAGNOSTICS AND THERAPEUTIC TARGETS
Start Date: 10-29-2018
End Date: 10-28-2019
Sponsor: NIH - NATIONAL CANCER INSTITUTE
A NOVEL APPROACH TO TREATING CASTRATION RESISTANT PROSTATE CANCER
Start Date: 6-1-2018
End Date: 1-31-2019
Sponsor: LIZANELL AND COLBERT COLDWELL FOUNDATION
DIRECT TARGETING OF THE FKBP52 COCHAPERONE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
Start Date: 7-1-2017
End Date: 6-30-2020
Sponsor: CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAM